These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. RiboaptDB: a comprehensive database of ribozymes and aptamers. Thodima V; Pirooznia M; Deng Y BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S6. PubMed ID: 17118149 [TBL] [Abstract][Full Text] [Related]
3. In vitro selection of hairpin ribozymes. Sargueil B; Burke JM Methods Mol Biol; 1997; 74():289-300. PubMed ID: 9204444 [No Abstract] [Full Text] [Related]
5. A general strategy for effector-mediated control of RNA-cleaving ribozymes and DNA enzymes. Wang DY; Lai BH; Sen D J Mol Biol; 2002 Apr; 318(1):33-43. PubMed ID: 12054766 [TBL] [Abstract][Full Text] [Related]
6. Competitive regulation of modular allosteric aptazymes by a small molecule and oligonucleotide effector. Najafi-Shoushtari SH; Famulok M RNA; 2005 Oct; 11(10):1514-20. PubMed ID: 16199761 [TBL] [Abstract][Full Text] [Related]
7. Computational design of allosteric ribozymes as molecular biosensors. Penchovsky R Biotechnol Adv; 2014; 32(5):1015-27. PubMed ID: 24877999 [TBL] [Abstract][Full Text] [Related]
8. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection. Tang J; Breaker RR RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650 [TBL] [Abstract][Full Text] [Related]
9. Exogenous control of mammalian gene expression through modulation of RNA self-cleavage. Yen L; Svendsen J; Lee JS; Gray JT; Magnier M; Baba T; D'Amato RJ; Mulligan RC Nature; 2004 Sep; 431(7007):471-6. PubMed ID: 15386015 [TBL] [Abstract][Full Text] [Related]
11. Stereospecificity of oligonucleotide interactions revisited: no evidence for heterochiral hybridization and ribozyme/DNAzyme activity. Hoehlig K; Bethge L; Klussmann S PLoS One; 2015; 10(2):e0115328. PubMed ID: 25679211 [TBL] [Abstract][Full Text] [Related]
12. Expanding the catalytic repertoire of ribozymes and deoxyribozymes beyond RNA substrates. Franzen S Curr Opin Mol Ther; 2010 Apr; 12(2):223-32. PubMed ID: 20373266 [TBL] [Abstract][Full Text] [Related]
13. Design of hairpin ribozymes for in vitro and cellular applications. Yu Q; Burke JM Methods Mol Biol; 1997; 74():161-9. PubMed ID: 9204431 [No Abstract] [Full Text] [Related]
14. A core folding model for catalysis by the hammerhead ribozyme accounts for its extraordinary sensitivity to abasic mutations. Peracchi A; Karpeisky A; Maloney L; Beigelman L; Herschlag D Biochemistry; 1998 Oct; 37(42):14765-75. PubMed ID: 9778351 [TBL] [Abstract][Full Text] [Related]
15. Dual-selection for evolution of in vivo functional aptazymes as riboswitch parts. Goler JA; Carothers JM; Keasling JD Methods Mol Biol; 2014; 1111():221-35. PubMed ID: 24549623 [TBL] [Abstract][Full Text] [Related]
18. Self-assembly of a group I intron from inactive oligonucleotide fragments. Hayden EJ; Lehman N Chem Biol; 2006 Aug; 13(8):909-18. PubMed ID: 16931340 [TBL] [Abstract][Full Text] [Related]
19. A computational approach to predict suitable target sites for trans-acting minimal hammerhead ribozymes. Mercatanti A; Lande C; Citti L Methods Mol Biol; 2012; 848():337-56. PubMed ID: 22315079 [TBL] [Abstract][Full Text] [Related]
20. RNA self-ligation: from oligonucleotides to full length ribozymes. Gwiazda S; Salomon K; Appel B; Müller S Biochimie; 2012 Jul; 94(7):1457-63. PubMed ID: 22465106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]